CN100492006C - 过滤仪及血液检测容器 - Google Patents
过滤仪及血液检测容器 Download PDFInfo
- Publication number
- CN100492006C CN100492006C CNB2003801036602A CN200380103660A CN100492006C CN 100492006 C CN100492006 C CN 100492006C CN B2003801036602 A CNB2003801036602 A CN B2003801036602A CN 200380103660 A CN200380103660 A CN 200380103660A CN 100492006 C CN100492006 C CN 100492006C
- Authority
- CN
- China
- Prior art keywords
- blood
- filtrator
- filtration members
- serum
- blood plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 221
- 239000008280 blood Substances 0.000 title claims abstract description 221
- 238000001514 detection method Methods 0.000 title 1
- 210000002381 plasma Anatomy 0.000 claims abstract description 175
- 210000002966 serum Anatomy 0.000 claims abstract description 131
- 238000000926 separation method Methods 0.000 claims abstract description 75
- 210000000601 blood cell Anatomy 0.000 claims abstract description 51
- 239000012528 membrane Substances 0.000 claims abstract description 49
- 238000001914 filtration Methods 0.000 claims description 155
- 238000012360 testing method Methods 0.000 claims description 76
- 239000000835 fiber Substances 0.000 claims description 54
- 230000004888 barrier function Effects 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 26
- 238000003860 storage Methods 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 239000003146 anticoagulant agent Substances 0.000 claims description 16
- 229940127219 anticoagulant drug Drugs 0.000 claims description 16
- 230000003746 surface roughness Effects 0.000 claims description 14
- 102000008946 Fibrinogen Human genes 0.000 claims description 7
- 108010049003 Fibrinogen Proteins 0.000 claims description 7
- 229940012952 fibrinogen Drugs 0.000 claims description 7
- 230000001723 fibrinogenic effect Effects 0.000 claims description 7
- 239000010422 internal standard material Substances 0.000 claims description 7
- 230000023555 blood coagulation Effects 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 abstract description 18
- 230000006378 damage Effects 0.000 abstract description 3
- 206010018910 Haemolysis Diseases 0.000 abstract description 2
- 230000008588 hemolysis Effects 0.000 abstract description 2
- 239000011800 void material Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 63
- 230000000052 comparative effect Effects 0.000 description 48
- 238000000034 method Methods 0.000 description 48
- 238000009792 diffusion process Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 14
- 239000005020 polyethylene terephthalate Substances 0.000 description 12
- 238000011144 upstream manufacturing Methods 0.000 description 12
- 229920004934 Dacron® Polymers 0.000 description 10
- 239000004417 polycarbonate Substances 0.000 description 9
- 229920000515 polycarbonate Polymers 0.000 description 9
- 238000013139 quantization Methods 0.000 description 9
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 238000005534 hematocrit Methods 0.000 description 8
- 229920000669 heparin Polymers 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 229960002897 heparin Drugs 0.000 description 7
- -1 polypropylene Polymers 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 5
- 108010073385 Fibrin Proteins 0.000 description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229950003499 fibrin Drugs 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 239000012858 resilient material Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229920001225 polyester resin Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- KJSGODDTWRXQRH-UHFFFAOYSA-N 2-(dimethylamino)ethyl benzoate Chemical compound CN(C)CCOC(=O)C1=CC=CC=C1 KJSGODDTWRXQRH-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- UMVOQQDNEYOJOK-UHFFFAOYSA-N 3,5-dimethylbenzoic acid Chemical compound CC1=CC(C)=CC(C(O)=O)=C1 UMVOQQDNEYOJOK-UHFFFAOYSA-N 0.000 description 1
- 108010027612 Batroxobin Proteins 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229960002210 batroxobin Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002905 metal composite material Substances 0.000 description 1
- MCPLVIGCWWTHFH-UHFFFAOYSA-L methyl blue Chemical compound [Na+].[Na+].C1=CC(S(=O)(=O)[O-])=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[NH+]C=2C=CC(=CC=2)S([O-])(=O)=O)C=2C=CC(NC=3C=CC(=CC=3)S([O-])(=O)=O)=CC=2)C=C1 MCPLVIGCWWTHFH-UHFFFAOYSA-L 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- QWYZFXLSWMXLDM-UHFFFAOYSA-M pinacyanol iodide Chemical compound [I-].C1=CC2=CC=CC=C2N(CC)C1=CC=CC1=CC=C(C=CC=C2)C2=[N+]1CC QWYZFXLSWMXLDM-UHFFFAOYSA-M 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 238000004441 surface measurement Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
孔的形状 | 微孔大小 | 过滤压力 | 血浆分离状态 | |
例4 | 通孔 | 0.2μm | 60kPa | 没有观察到血细胞溶解 |
例5 | 通孔 | 0.8μm | 60kPa | 没有观察到血细胞溶解 |
对比例4 | 连续通气孔 | 0.65μm | 20kPa | 观察到血细胞溶解 |
对比例5 | 通孔 | 3.0μm | 20kPa | 红血球渗出 |
微孔大小 | 孔隙率 | 过滤压力 | 血浆分离状态 | |
例10 | 0.2μm | 14% | 60kPa | 没有观察到血细胞溶解 |
例11 | 0.8μm | 16% | 60kPa | 没有观察到血细胞溶解 |
例12 | 2.0μm | 8% | 60kPa | 没有观察到血细胞溶解 |
对比例10 | 0.22μm | 70% | 20kPa | 观察到血细胞溶解 |
对比例11 | 0.65μm | 81% | 20kPa | 观察到血细胞溶解 |
对比例12 | 3.0μm | 14% | 20kPa | 红血球渗出 |
测试例5的结果 | 测试例6的结果 | |
例13 | 没有血细胞溶解 | 轻微血细胞溶解 |
例14 | 没有血细胞溶解 | 没有血细胞溶解 |
例15 | 没有血细胞溶解 | 没有血细胞溶解 |
对比例13 | 没有血细胞溶解 | 微弱血细胞溶解 |
深针端直径 | 材料 | 悬臂长度 | 弹簧常数 | |
AFM | 10nm | 氮化硅 | 100μm | 0.09N/m |
DFM | 10nm | 硅 | 100μm | 20.0N/m |
平均表面粗糙度 | 微孔大小 | 过滤压力 | 血浆分离状态 | |
例16 | 58.62nm | 0.4μm | 60kPa | 没有血细胞溶解 |
例17 | 24.63nm | 0.4μm | 60kPa | 没有血细胞溶解 |
例18 | 27.53nm | 0.4μm | 60kPa | 没有血细胞溶解 |
对比例14 | 147.70nm | 0.45μm | 60kPa | 有血细胞溶解 |
平均表面粗糙度 | 微孔大小 | 过滤压力 | 血液分离状态 | 样本血量 | 剩余纤维蛋白原量* | |
例19 | 58.62nm | 0.4μm | 60kPa | 没有血细胞溶解 | 0.52mL | 量化限制量或更小 |
例20 | 24.63nm | 0.4μm | 60kPa | 没有血细胞溶解 | 0.53mL | 量化限制量或更小 |
例21 | 27.53nm | 0.4μm | 60kPa | 没有血细胞溶解 | 0.52mL | 量化限制量或更小 |
对比例15 | 147.70nm | 0.45μm | 60kPa | 没有血细胞溶解 | 0.52mL | 量化限制量或更小 |
平均表面粗糙度 | 微孔大小 | 过滤压力 | 血液分离状态 | 样本血量 | 剩余纤维蛋白原量* | |
例22 | 58.62nm | 0.4μm | 60kPa | 没有血细胞溶解 | 0.74mL | 量化限制量或更小 |
例23 | 58.63nm | 0.4μm | 60kPa | 0.79mL | 量化限制量或更小 | |
例24 | 58.64nm | 0.4μm | 60kPa | 0.76mL | 量化限制量或更小 |
Claims (13)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP335606/2002 | 2002-11-19 | ||
JP2002335606 | 2002-11-19 | ||
JP124335/2003 | 2003-04-28 | ||
JP335607/2002 | 2006-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1714292A CN1714292A (zh) | 2005-12-28 |
CN100492006C true CN100492006C (zh) | 2009-05-27 |
Family
ID=35719256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003801036602A Expired - Lifetime CN100492006C (zh) | 2002-11-19 | 2003-11-18 | 过滤仪及血液检测容器 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100492006C (zh) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2264453B1 (en) * | 2009-06-17 | 2013-04-03 | Leukocare Ag | Method for filtering blood |
WO2014024157A1 (en) * | 2012-08-08 | 2014-02-13 | Koninklijke Philips N.V. | Plasma separation using a drop of blood |
CN103293049A (zh) * | 2013-05-27 | 2013-09-11 | 苏州扬清芯片科技有限公司 | 一种血清分离方法及装置 |
US9568404B2 (en) * | 2014-05-16 | 2017-02-14 | Junyu Mai | Method and apparatus for biomolecule analysis |
US10712245B2 (en) * | 2014-12-16 | 2020-07-14 | Foss Analytical A/S | Filtration system for liquid samples |
CN105985903A (zh) * | 2015-02-12 | 2016-10-05 | 谭巍 | 细胞收集装置及其应用 |
CN104921760B (zh) * | 2015-07-13 | 2017-09-12 | 上海慧晨生物医学科技有限公司 | 收集保存体液的装置及使用方法 |
CA2996863C (en) * | 2015-09-01 | 2021-04-13 | Becton, Dickinson And Company | Depth filtration device for separating specimen phases |
CN105445083B (zh) * | 2015-12-21 | 2018-09-11 | 丹娜(天津)生物科技有限公司 | 免离心全血处理模块 |
JP6366025B2 (ja) * | 2016-10-03 | 2018-08-01 | セルスペクト株式会社 | 血漿分離装置及び血漿分離方法 |
CN106526007B (zh) * | 2016-10-26 | 2019-10-25 | 上海万承生物科技有限公司 | 一种检测血浆活性成分方法及应用该方法的血浆卡 |
TWI674138B (zh) * | 2017-04-07 | 2019-10-11 | 泰博科技股份有限公司 | 濾血裝置及濾血方法 |
MX2019014525A (es) | 2017-06-08 | 2020-02-10 | Becton Dickinson Co | Dispositivo de separacion de liquidos biologicos. |
CN107475094B (zh) * | 2017-08-11 | 2021-01-26 | 河南科技大学第一附属医院 | 一种血细胞分离管和分离方法 |
CN107669281A (zh) * | 2017-11-02 | 2018-02-09 | 犹银俊 | 动物血清采集试管及血清分离器 |
CN108359592B (zh) * | 2018-03-05 | 2021-05-28 | 东营凤起生物科技发展有限公司 | 一种医用造血干细胞采集仪 |
CN108607364A (zh) * | 2018-05-03 | 2018-10-02 | 湖南乐准智芯生物科技有限公司 | 一种涡流管及血浆微滤结构 |
EP4001916A1 (en) * | 2018-06-07 | 2022-05-25 | Becton, Dickinson and Company | Biological fluid separation device |
CN109157228A (zh) * | 2018-06-26 | 2019-01-08 | 南京工业大学 | 一种即时血清分离的采血管 |
CN108905630A (zh) * | 2018-08-30 | 2018-11-30 | 南京工业大学 | 一种快速血清提取器 |
CN109529444A (zh) * | 2018-12-17 | 2019-03-29 | 刘向晖 | 一种去除血液样本中血细胞的过滤技术及过滤器 |
CN109663385B (zh) * | 2019-02-25 | 2024-03-12 | 上海输血技术有限公司 | 一种血浆亚甲蓝病毒灭活过滤装置及其制备方法 |
CN111789601A (zh) * | 2019-04-09 | 2020-10-20 | 李泉 | 血液过滤器及血液过滤设备 |
CN114765966A (zh) * | 2019-10-23 | 2022-07-19 | Tl 基因体科技株式会社 | 血液用装置 |
CN114414306A (zh) * | 2022-01-13 | 2022-04-29 | 杭州安旭生物科技股份有限公司 | 一种样本采集装置及样本采集方法 |
-
2003
- 2003-11-18 CN CNB2003801036602A patent/CN100492006C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1714292A (zh) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100492006C (zh) | 过滤仪及血液检测容器 | |
CA2504603C (en) | Plasma or serum separation membrane and filter apparatus including the plasma or serum separation membrane | |
US6241886B1 (en) | Plasma separation filter | |
JP4387166B2 (ja) | 血漿もしくは血清分離膜を用いたフィルタ装置及び血漿もしくは血清分離方法 | |
US9028688B2 (en) | Instrument for separating blood and apparatus for separating blood | |
EP0893130B1 (en) | Method of filtering blood | |
US5996811A (en) | Plasma collecting device | |
DE68923902T2 (de) | Gerät zur Trennung der Blutphasen. | |
JPH10508343A (ja) | 繊維質ウェブ及びその製造方法 | |
US20060016747A1 (en) | Glass-fiber filter for blood filtration, blood filtration device and blood analysis element | |
US7059480B2 (en) | Continuous blood filtration apparatus | |
EP0937981B1 (en) | Method of separating serum from whole blood | |
US6375856B1 (en) | Method of recovering blood filtration residues | |
JP4113464B2 (ja) | 血液検査用容器及び血液検査方法 | |
JP3644169B2 (ja) | 血漿あるいは血清分離フィルターおよび血漿あるいは血清分離方法 | |
JP2007003482A (ja) | 臨床検査キット | |
JP2526889Y2 (ja) | 採漿容器 | |
JPH1138003A (ja) | 血液濾過装置 | |
JPH11295298A (ja) | 血液濾過ユニット | |
JPH10227788A (ja) | 血液濾過ユニット | |
JP2012088089A (ja) | 臨床検査キットおよび血液の検査方法 | |
JP2003149234A (ja) | 血液成分の分離方法及び血液成分分離装置 | |
JPH10170508A (ja) | 血液濾過方法 | |
JPH10185909A (ja) | 血液濾過ユニット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SEKISUI CHEMICAL CO., LTD.; APPLICANT Free format text: FORMER OWNER: SEKISUI CHEMICAL CO., LTD. Effective date: 20080404 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080404 Address after: Osaka, Japan Applicant after: SEKISUI CHEMICAL Co.,Ltd. Co-applicant after: Edison Co.,Ltd. Co-applicant after: Nittobo Medicine Co.,Ltd. Co-applicant after: TOYOBO CO.,LTD. Address before: Osaka, Japan Applicant before: SEKISUI CHEMICAL Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SEKISUI MEDICAL TREATMENT CO., LTD.; APPLICANT Free format text: FORMER OWNER: SEKISUI CHEMICAL CO., LTD.; APPLICANT Effective date: 20080808 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080808 Address after: Osaka, Japan Applicant after: SEKISUI MEDICAL Co.,Ltd. Co-applicant after: Edison Co.,Ltd. Co-applicant after: Nittobo Medicine Co.,Ltd. Co-applicant after: TOYOBO CO.,LTD. Address before: Osaka, Japan Applicant before: SEKISUI CHEMICAL Co.,Ltd. Co-applicant before: Edison Co.,Ltd. Co-applicant before: Nittobo Medicine Co.,Ltd. Co-applicant before: TOYOBO CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110714 Address after: Osaka, Japan Co-patentee after: Nittobo Medicine Co.,Ltd. Patentee after: SEKISUI MEDICAL Co.,Ltd. Co-patentee after: TOYOBO CO.,LTD. Address before: Osaka, Japan Co-patentee before: Edison Co.,Ltd. Patentee before: SEKISUI MEDICAL Co.,Ltd. Co-patentee before: Nittobo Medicine Co.,Ltd. Co-patentee before: TOYOBO CO.,LTD. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20090527 |